Qiurong Ruan

Qiurong Ruan

Auto-generated profile, based on publicly available information

Qiurong Ruan

Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2020 in Intensive Care Medicine
Verified
Journal Article
Open access
PDF file
QRQiurong Ruan
Qiurong Ruan
KYKun Yang
Kun Yang
WWWenxia Wang
Wenxia Wang
LJLingyu Jiang
Lingyu Jiang
JSjianxin song
jianxin song

6 April 2020 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
QRQiurong Ruan
Qiurong Ruan
KYKun Yang
Kun Yang
WWWenxia Wang
Wenxia Wang
LJLingyu Jiang
Lingyu Jiang
JSjianxin song
jianxin song

1 May 2010 in Journal of Cardiovascular Pharmacology
Verified
Journal Article
Closed access
JYJun Yu
Jun Yu
MLMincai Li
Mincai Li
ZQZhiling Qu
Zhiling Qu
DYDan Yan
Dan Yan
DLDujuan Li
Dujuan Li
QRQiurong Ruan
Qiurong Ruan
Stromal cell-derived factor-1 (SDF-1) and its receptor, CXCR4, are crucial for homing and migration of multiple stem cell types. Their potential role in mediating bone marrow-derived mesenchymal stem cell (BMSC) migration in areas of myocardial infarction (MI) has not been demonstrated. In this study, rat heart MI was created by left coronary artery ligation, and green fluorescent protein-labeled BMSCs were directly infused into the left ventricular cavity. Reverse transcriptase-polymerase chain reaction and Western blot analysis showed that SDF-1 was predominantly localized in the MI lesion, and its levels peaked by 3 to 7 days and were maintained at least 14 days. Additionally, this was matched with increased accumulation of BMSCs and an improvement in cardiac function. Furthermore, this effect was blocked by the phosphoinositide 3-kinase inhibitor, LY294002. In vitro experiments showed that CXCR4 expression by BMSCs was elevated during hypoxia and SDF-1 induced a concentration-dependent migration of BMSCs. This migration was CXCR4-dependent as confirmed by its total inhibition by AMD3100, a CXCR4-specific antagonist. Migration was also almost completely blocked by LY294002. Analysis showed that phosphorylated Akt was highly increased in SDF-1-treated BMSCs. Together these results demonstrated that SDF-1/CXCR4 may mediate the migration of BMSCs toward heart MI through activation of PI3K/Akt.

1 January 2015 in Disease Markers
Verified
Journal Article
Open access
PDF file
JDJun Dai
Jun Dai
LYLili Yang
Lili Yang
JWJinyu Wang
Jinyu Wang
YXYing Xiao
Ying Xiao
QRQiurong Ruan
Qiurong Ruan
Forkhead box M1 (FOXM1), a member of the Fox transcription factors family, was closely related with cell cycle. FOXM1 played an important role in MST and prompted a poor prognosis for MST patients. However, there were also some studies revealing no significant association between the FOXM1 expression and prognosis of patients. Therefore, we conducted meta-analysis to investigate whether the expression of FOXM1 was associated with MST prognosis. We collected 36 relevant studies through PubMed database and obtained research data of 4946 patients. Stata 12.0 was used to express the results as hazard ratio (HR) for time-to-event outcomes with 95% confidence intervals (95% CI). It was shown that overexpression of FOXM1 was relevant to worse survival of MST patients (HR = 1.99, 95% CI = 1.79–2.21,P<0.001;I2=26.4%,Ph=0.076). Subgroup analysis suggested that overexpression of FOXM1 in breast cancer (BC), gastric cancer (GC), hepatocellular carcinoma (HCC), pancreatic ductal adenocarcinoma (PDA), and non-small-cell lung cancer (NSCLC) all predicted a worse survival (P<0.05), in addition to ovarian cancer (OC) (P=0.084). In conclusion, our research indicated that overexpression of FOXM1 was to the disadvantage of the prognosis for majority of MST and therefore can be used as an evaluation index of prognosis.

1 June 2014 in Experimental and Molecular Pathology
Verified
Journal Article
Closed access
WLWeishuo Liu
Weishuo Liu
JJJianwei Jiang
Jianwei Jiang
DYDan Yan
Dan Yan
DLDujuan Li
Dujuan Li
WLWei Li
Wei Li
QRQiurong Ruan
Qiurong Ruan

28 October 2022 in EJNMMI Research
Verified
Journal Article
Open access
PDF file
JCJia Chen
Jia Chen
MXMingYou Xing
MingYou Xing
DXDong Xu
Dong Xu
NXNaNa Xie
NaNa Xie
WZWenCong Zhang
WenCong Zhang
JSjianxin song
jianxin song
Background: This study aims to analyze the 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) characteristics of different causes of fever of unknown origin (FUO) and identify independent predictors to develop a suitable diagnostic model for distinguishing between these causes. A total of 524 patients with classical FUO who underwent standard diagnostic procedures and PET/CT were prospectively studied. The diagnostic performance of PET/CT imaging was analyzed, and relevant clinical parameters that could improve diagnostic efficacy were identified. The model was established using the data of 369 patients and the other 155 patients comprised the validation cohort for verifying the diagnostic performance of the model. Results: The metabolic characteristics of the “hottest” lesion, the spleen, bone marrow, and lymph nodes varied for various causes. PET/CT combined with clinical parameters achieved better discrimination in the differential diagnosis of FUO. The etiological diagnostic models included the following factors: multisite metabolic characteristics, blood cell counts, inflammatory indicators (erythrocyte sedimentation rate, C-reactive protein, serum ferritin, and lactate dehydrogenase), immunological indicators (interferon gamma release assay, antinuclear antibody, and anti-neutrophil cytoplasm antibody), specific signs (weight loss, rash, and splenomegaly), and age. In the testing cohort, the AUCs of the infection prediction model, the malignancy diagnostic model, and the noninfectious inflammatory disease prediction model were 0.89 (95% CI 0.86–0.92), 0.94 (95% CI 0.92–0.97), and 0.95 (95% CI 0.93–0.97), respectively. The corresponding AUCs for the validation cohort were 0.88 (95% CI 0.82–0.93), 0.93 (95% CI 0.89–0.98), and 0.95 (95% CI 0.92–0.99), respectively. Conclusions: 18F-FDG PET/CT has a certain level of sensitivity and accuracy in diagnosing FUO, which can be further improved by combining it with clinical parameters. Diagnostic models based on PET/CT show excellent performance and can be used as reliable tools to discriminate the cause of FUO. Trial registration This study (a two-step method apparently improved the physicians’ level of diagnosis decision-making for adult patients with FUO) was registered on the website http://www.clinical-trials.gov on January 14, 2014, with registration number NCT02035670.